Brought to you by 
Boehringer Ingelheim increases stake in Japan's SSP
25 Feb 2010
Executive Summary
Nippon Boehringer Ingelheim, Boehringer Ingelheim GMBH's Japanese subsidiary, has increased its equity stake by 14.37% in longtime partner SSP Co. Ltd. (formerly known as SS Pharmaceutical Co.), a public Japanese pharmaceutical company, in which Nippon took an initial stake of 9.2% in 1996, increasing it to 35.86% in February 2000. Nippon will now hold 50.23% of SSP's shares (52.24% upon the exercise of convertible bonds).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boehringer Ingelheim increases stake in Japan's SSP
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice